Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mendis

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neuropsychobiology|January 1, 1979
Effect of benztropine on haloperidol-induced prolactin secretionS Lal, T Mendis, P Cervantes, et al.
Clinical Neuropharmacology|February 1, 1995
Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's diseaseE Mohr, V Knott, M Sampson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2008
Impact of standard of care for psychosis in Parkinson diseaseT R Thomsen, M Panisset, O Suchowersky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxiprideT Mendis, E Mohr, A George, et al.
Neurology|June 4, 2008
A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson diseaseM Stacy, D Silver, T Mendis, et al.
Clinical Neuropharmacology|August 1, 1997
Treatment of Alzheimer's disease with sabeluzole: functional and structural correlatesE Mohr, N P Nair, M Sampson, et al.
Lancet (London, England)|March 4, 1978
Clinical effects of choline in Alzheimer's diseaseP Etienne, S Gauthier, G Johnson, et al.
Journal of Medicinal Chemistry|May 13, 2015
New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide SynthaseWei Li, Suqing Zheng, Maureen Higgins, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neuropsychobiology|January 1, 1979
Effect of benztropine on haloperidol-induced prolactin secretionS Lal, T Mendis, P Cervantes, et al.
Clinical Neuropharmacology|February 1, 1995
Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's diseaseE Mohr, V Knott, M Sampson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2008
Impact of standard of care for psychosis in Parkinson diseaseT R Thomsen, M Panisset, O Suchowersky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1994
Symptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxiprideT Mendis, E Mohr, A George, et al.
Neurology|June 4, 2008
A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson diseaseM Stacy, D Silver, T Mendis, et al.
Clinical Neuropharmacology|August 1, 1997
Treatment of Alzheimer's disease with sabeluzole: functional and structural correlatesE Mohr, N P Nair, M Sampson, et al.
Lancet (London, England)|March 4, 1978
Clinical effects of choline in Alzheimer's diseaseP Etienne, S Gauthier, G Johnson, et al.
Journal of Medicinal Chemistry|May 13, 2015
New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide SynthaseWei Li, Suqing Zheng, Maureen Higgins, et al.
Pageof 2